According to the Zhitong Finance App, Shiyao Group (01093.HK) announced that the daretuizumab injection developed by the Group has been approved by the China Drug Administration and can conduct clinical trials in China.

According to the Zhitong Finance App, Shiyao Group (01093.HK) announced that the daretuizumab injection developed by the Group has been approved by the China Drug Administration and can conduct clinical trials in China.